Detailed information about shipments of injectable steroids implicated in the fungal meningitis outbreak are now available from the Food and Drug Administration.
Physicians who need to identify patients injected with fungus-contaminated steroids can now obtain detailed information from the FDA, listing customers who received shipments and the specific contaminated products shipped by New England Compounding Center's Framingham MA facility after May 21, the first known date when implicated products were distributed.
Further information is available in a MedWatch Safety Alert on the fungal meningitis outbreak.
The number of contaminated injections is now up to 297, in 23 states. The death toll to date is 23. Up-to-date information is available from the Center for Disease Control and Prevention's web page on the Multistate Fungal Meningitis Outbreak Investigation.